What is the treatment for a burning sensation in the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Burning Foot Sensation

For burning foot pain, the treatment approach depends critically on the underlying cause: diabetic peripheral neuropathy requires glycemic optimization and neuropathic pain medications, while erythromelalgia responds to cooling measures and aspirin (if secondary to myeloproliferative disease), and small fiber neuropathy may benefit from topical agents like lidocaine or capsaicin. 1

Initial Assessment and Diagnosis

The first step is determining whether this represents:

  • Diabetic peripheral neuropathy (DPN): Most common cause, presents with symmetrical "glove and stocking" distribution, associated with numbness, tingling, and loss of protective sensation 1
  • Erythromelalgia: Episodes of severe burning pain with striking redness and warmth, precipitated by heat/activity, relieved only by cooling 1, 2
  • Small fiber neuropathy: Burning sensation without large fiber involvement, often with normal neurological examination 1
  • Secondary causes: Medication-induced (chemotherapy), vitamin deficiencies, or myeloproliferative disorders 1

Key examination findings to assess:

  • 10-g monofilament testing with at least one additional test (pinprick, temperature, vibration using 128-Hz tuning fork) 1
  • Pedal pulses and signs of peripheral arterial disease 1
  • Skin inspection for redness, warmth, and whether cooling provides relief 1
  • History of diabetes, chemotherapy, alcohol use, or vitamin deficiencies 1

Treatment Algorithm by Etiology

For Diabetic Peripheral Neuropathy

Optimize glycemic control first - this is the only intervention that modifies the underlying disease process 1

Pharmacologic pain management:

  • Start with FDA-approved agents: pregabalin, duloxetine, or tapentadol 1
  • Tricyclic antidepressants (amitriptyline, nortriptyline) are effective but have more side effects in elderly patients 1
  • Gabapentin can be used as alternative to pregabalin 1

Topical options as first-line or adjunctive therapy:

  • Lidocaine patches or cream for localized pain 3
  • Capsaicin cream 0.075% applied 3-4 times daily (expect initial burning that decreases with regular use) 4
  • Warning with capsaicin: Do not use on damaged skin, avoid eyes/mucous membranes, do not apply heat or tight bandages, and discontinue if severe burning persists or blistering occurs 4

Foot care essentials:

  • Daily foot inspection for early problem detection 1
  • Well-fitted therapeutic footwear to redistribute pressure 1
  • Avoid walking barefoot 1

For Erythromelalgia

Non-pharmacologic management (first-line):

  • Cooling measures: Elevate extremities, use fans, but strictly limit water/ice immersion to maximum 10 minutes, 4 times daily to prevent tissue damage, ulceration, and "immersion foot" 1
  • Avoid heat triggers and excessive exercise 1
  • Consider swimming instead of running for exercise 1

Topical treatments (first-line pharmacologic):

  • Topical lidocaine, capsaicin, or other agents can be effective with fewer systemic side effects 1
  • Apply before anticipated triggering activities 1

Systemic medications:

  • Aspirin is first-line for secondary erythromelalgia due to myeloproliferative disease 1
  • For refractory cases, multiple agents have been tried with variable success (gabapentin, pregabalin, sodium channel blockers) 1
  • Refer to comprehensive pain rehabilitation center for severe, disabling cases 1

For Small Fiber Neuropathy

Topical agents are preferred first-line:

  • Lidocaine patches/cream 3
  • Capsaicin cream (with appropriate warnings about initial burning) 4

Systemic neuropathic pain medications if topical therapy insufficient:

  • Gabapentin or pregabalin 1
  • Duloxetine or tricyclic antidepressants 1

For Chemotherapy-Induced Peripheral Neuropathy

Prevention is key - dose reduction or treatment interruption may be necessary if severe symptoms develop 1

Symptomatic management:

  • Similar neuropathic pain medications as for DPN 1
  • Topical agents for localized symptoms 1
  • Physical therapy and continued activity (does not worsen long-term outcomes) 1

Common Pitfalls and Caveats

Critical mistakes to avoid:

  • Do not allow prolonged ice/water immersion in erythromelalgia patients - this causes tissue damage despite providing temporary relief 1
  • Do not apply ice directly to skin for any burning sensation - wrap in cloth if ice must be used 1, 5
  • Do not dismiss burning feet as purely psychological - there is often underlying neuropathy even when examination is normal 6, 7
  • Do not use capsaicin on broken or damaged skin 4
  • Do not stop GLP-1 receptor agonists solely for gastroparesis concerns without weighing cardiovascular/glycemic benefits 1

When to refer urgently:

  • Progressive weakness or rapid symptom progression 1
  • Signs of critical limb ischemia (absent pulses, rest pain, tissue loss) 1
  • Suspected Charcot foot (acute red, hot, swollen foot in patient with neuropathy) 1
  • Severe refractory pain affecting quality of life 1

Special populations:

  • Patients on dialysis or with prior amputation require interprofessional foot care team 1
  • Smokers with neuropathy need aggressive smoking cessation counseling and foot care specialist referral 1

Monitoring and Follow-up

  • Annual comprehensive foot examination for all diabetic patients, more frequently if high-risk features present 1
  • Reassess at every visit if prior ulceration, amputation, or loss of protective sensation 1
  • Titrate neuropathic pain medications based on response and tolerability 1
  • Monitor for medication side effects, particularly sedation and dizziness with gabapentinoids 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hot feet: erythromelalgia and related disorders.

Journal of child neurology, 2001

Guideline

Management of Burning Pain at IV Site

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Burning feet syndrome. A clinical review.

Australian family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.